Literature DB >> 3815585

Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II).

P Bedford, M C Walker, H L Sharma, A Perera, C A McAuliffe, J R Masters, B T Hill.   

Abstract

A two-fold difference in sensitivity to cis-diamminedichloroplatinum(II) (cisplatin), as judged by colony forming assays, has been demonstrated in two human bladder carcinoma continuous cell lines. Approximately twice as many DNA-DNA interstrand cross-links (ISL) and a 2-fold greater inhibition of DNA synthesis occurred in the more sensitive T24 cell line than in the RT112 cell line after exposure to the same concentrations of cisplatin. Equitoxic concentrations of cisplatin resulted in similar extents of ISL and inhibition of DNA synthesis in both cell lines. Although drug uptake was identical, twice as much cisplatin was bound to the DNA of T24 cells than RT112 cells. However after equitoxic concentrations of cisplatin the DNA from both cell lines was platinated to a similar extent. In addition, levels of glutathione (GSH), glutathione reductase (GR) and total glutathione-S-transferases (GST) were higher in the less sensitive RT112 cell line.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3815585     DOI: 10.1016/0009-2797(87)90015-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.

Authors:  G Chen; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 2.  Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

Authors:  A de Graeff; R J Slebos; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.

Authors:  Julie Scott; Robert T Dorr; Betty Samulitis; Terry H Landowski
Journal:  Cancer Chemother Pharmacol       Date:  2007-02-28       Impact factor: 3.333

4.  Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells.

Authors:  S Ohno; Z H Siddik; Y Kido; L A Zwelling; J M Bull
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Intracellular glutathione and cytotoxicity of platinum complexes.

Authors:  L Pendyala; P J Creaven; R Perez; J R Zdanowicz; D Raghavan
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder.

Authors:  Nathalie van den Tempel; Kishan A T Naipal; Anja Raams; Dik C van Gent; Martine Franckena; Joost L Boormans; Roland Kanaar
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

7.  Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.

Authors:  S Inoue; S Mizuno; M Ito; T Ohnuma
Journal:  Jpn J Cancer Res       Date:  1992-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.